Enlitic Inc Chess Depository intrests Repr 1 Shs
AASX:ENL0.03
AUD
+0.00
(+6.25%)
ISIN
AU0000305427
Return %
Stock
S&P 500
1Y
-87.86
14.20
3Y
- -
81.12
5Y
- -
68.34
Capital Structure
USD
•
in mil. unless spec.Working Capital
USD
•
in mil. unless spec.Growth Rates
USD
•
in mil. unless spec.Quarterly Revenue
USD
•
in mil. unless spec.Quarterly Earnings Per Share
USD
•
in mil. unless spec.Quarterly Dividends Per Share
USD
•
in mil. unless spec.Company Description
- CEO
- Michael Karlgerhard Sistenich
- Full Time Employees
- 89
- Sector
- Technology services
- Industry
- Packaged software
- Address
- 1635 Foxtrail Drive Fort Collins CO United States 80538
- IPO Date
- Dec 18, 2023
- Website
- enlitic.com
- Similar Companies
- Business
- Enlitic Inc (ASX:ENL) develops artificial intelligence-enabled solutions for healthcare data management, focusing on medical imaging standardization, anonymization, and migration to enhance clinical workflows, operational efficiency, and revenue opportunities for providers. The company offers ENDEX, an AI platform that standardizes DICOM medical imaging data for consistency across sources; ENCOG, an AI-driven data anonymization tool that protects health information while preserving clinical relevance; Migratek, an AI-enabled solution for large-scale data migration and routing services; and the Ensight Framework, which integrates these applications to enable data analysis, research, and workflow optimization for radiologists, IT professionals, executives, and researchers. Enlitic operates in the United States, Europe, and Japan through its software and migration services segments, targeting hospitals, clinics, radiology centers, research institutes, pharmaceuticals, and healthcare vendors. Founded in 2014 and headquartered in Fort Collins, Colorado, the company acquired Laitek Inc in 2025 for AU$22.5 million in equity funding to integrate advanced medical imaging data migration expertise, enhancing its AI standardization capabilities and market positioning. In May 2025, Enlitic entered a binding memorandum of understanding with GE HealthCare, potentially worth up to A$50 million over five years, under which its subsidiary Laitek provides migration services with a US$2 million prepayment contingent on A$10 million funding, which the company secured via a placement of CDIs.